Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchitra Acharya

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Seminars in Thrombosis and Hemostasis|September 19, 2024
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT TrialHope P Wilson, Maua Mosha, Alexandra Miller, et al.
Blood Vessels, Thrombosis & Hemostasis|August 18, 2025
Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohortMarilyn J Manco-Johnson, Binh Le, Suchitra Acharya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2021
The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia BJan Astermark, Katharina Holstein, Yasmina L Abajas, et al.
Blood|May 20, 2018
Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathwayColine Haxaire, Narine Hakobyan, Tania Pannellini, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remainErik Berntorp, Petra LeBeau, Margaret V Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)Amy D Shapiro, Margaret V Ragni, Munira Borhany, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Seminars in Thrombosis and Hemostasis|September 19, 2024
Secondary Anticoagulation Use in Patients < 21 Years Old following Primary Anticoagulant Treatment for Provoked Venous Thromboembolism: Findings from the Kids-DOTT TrialHope P Wilson, Maua Mosha, Alexandra Miller, et al.
Blood Vessels, Thrombosis & Hemostasis|August 18, 2025
Risk factors for joint bleeding in severe hemophilia A and B: analysis of the Community Counts longitudinal surveillance cohortMarilyn J Manco-Johnson, Binh Le, Suchitra Acharya, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 12, 2021
The B-Natural study-The outcome of immune tolerance induction therapy in patients with severe haemophilia BJan Astermark, Katharina Holstein, Yasmina L Abajas, et al.
Blood|May 20, 2018
Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathwayColine Haxaire, Narine Hakobyan, Tania Pannellini, et al.
Blood Vessels, Thrombosis & Hemostasis|July 1, 2026
Safety and real-world effectiveness of eptacog beta with emicizumab prophylaxis: an interim analysis of the ATHN 16 studyTammuella Chrisentery-Singleton, Suchitra Acharya, Sanjay Ahuja, et al.
Blood|July 3, 2025
Marstacimab Prophylaxis in Hemophilia A/B Without Inhibitors: Results from the Phase 3 BASIS TrialDavide Matino, Andrew Palladino, Carrie Turich Taylor, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 9, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remainErik Berntorp, Petra LeBeau, Margaret V Ragni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 5, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)Amy D Shapiro, Margaret V Ragni, Munira Borhany, et al.
Pageof 3